A new report from the National Academies of Sciences, Engineering, and Medicine recommends two frameworks that medical professional societies, health care organizations, and state, national and local agencies could use to develop clinical practice guidelines for prescribing opioids to manage acute pain. Requested by the Food and Drug Administration, the report also identifies surgical procedures and acute medical conditions for which evidence-based guidelines would be desirable. Janet Woodcock, M.D., director of FDA’s Center for Drug Evaluation and Research, said the agency will consider the recommendations as it develops evidence-based prescribing guidelines for treating acute pain in therapeutic areas for which guidelines do not exist.

Related News Articles

Headline
The AHA will host a webinar Dec. 18 at 1 p.m. ET on strategies to better protect senior leaders in hospitals. Attendees will learn ways to reduce…
Headline
A JAMA article co-authored by AHA Chief Physician Executive Chris DeRienzo, M.D., and leaders from Vizient highlights that hospitals and health systems have…
Headline
ByHeart has expanded its voluntary recall to include all Whole Nutrition Infant Formula cans and Anywhere Pack products amid an investigation by the Food and…
Headline
A study published today by Nature found that as many as 5,000 steps per day can slow cognitive decline for individuals with early signs of Alzheimer’s disease…
Headline
Rural hospital leaders recently shared strategies and insights on improving safety culture, governance and care reliability at the AHA’s Rural Patient Safety…
Headline
The Food and Drug Administration sent a warning letter to Philips last month due to quality violations found at three of its medical device facilities earlier…